NCT02959476View on ClinicalTrials.gov

Ropivacaine 0.2% Pre-Filled Dispenser for the Treatment of Postsurgical Pain in Patients Undergoing Cesarean Delivery

PHASE3CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

March 13, 2017

Primary Completion Date

August 10, 2018

Study Completion Date

August 10, 2018

Conditions
Pain, Postoperative
Interventions
DRUG

Ropivacaine

Anesthetic

DRUG

Placebos

Inactive comparator

Trial Locations (11)

26506

West Virginia University, Morgantown

27606

Duke University Medical Center, Durham

33414

Vision Clinical Research, Wellington

35205

Clinical Research Associates, Inc., Birmingham

35660

Shoals Medical Trials, Inc., Sheffield

39531

MedPharmics, LLC, Biloxi

77702

Compass Clinical Trial, Beaumont

83404

Clinical Research Prime, Idaho Falls

84020

Physician's Research Options, LLC- Corner Canyon OB/GYN, Draper

84112

Health Sciences Center- University of Utah, Salt Lake City

92868

University of California, Irvine, Orange

Sponsors

Lead Sponsor

BioQ Pharma, Inc.

Collaborators (1)

Premier Research
All Listed Sponsors
collaborator

Premier Research

OTHER

lead

BioQ Pharma, Inc.

INDUSTRY

NCT02959476 - Ropivacaine 0.2% Pre-Filled Dispenser for the Treatment of Postsurgical Pain in Patients Undergoing Cesarean Delivery | Biotech Hunter | Biotech Hunter